We next compared the transcriptomes of purified CD138+ malignant plasma cells from the high-risk subset of MM patients (N = 63) with the transcriptomes of CD138+ normal plasma cells in control samples (N = 7). This evidence concerns the gene SDC1 and Miyoshi myopathy.